The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase epsilon

The recent discovery of mutations in the gene encoding diacylglycerol kinase epsilon (DGKE) identified a novel pathophysiologic mechanism leading to HUS and/or MPGN. We report ten new patients from eight unrelated kindreds with DGKE nephropathy. We combined these cases with all previously published...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Azukaitis K Karolis
Simkova E Eva
Majid MA Mohammad Abdul
Galiano Matthias
Benz Kerstin
Amann Kerstin
Bockmeyer Clemens
Gajjar Radha
Meyers Kevin E.
Cheong Hae II
Lange-Sperandio Bärbel
Jungraithmayr Therese
Bereczki Csaba
Csuka Dorottya
Prohászka Zoltán
Dokumentumtípus: Cikk
Megjelent: 2017
Sorozat:JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28 No. 10
doi:10.1681/ASN.2017010031

mtmt:3269673
Online Access:http://publicatio.bibl.u-szeged.hu/17677
LEADER 02906nab a2200373 i 4500
001 publ17677
005 20220210082056.0
008 191218s2017 hu o 0|| zxx d
022 |a 1046-6673 
024 7 |a 10.1681/ASN.2017010031  |2 doi 
024 7 |a 3269673  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 2 |a Azukaitis K Karolis 
245 1 4 |a The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase epsilon  |h [elektronikus dokumentum] /  |c  Azukaitis K Karolis 
260 |c 2017 
300 |a 3066-3075 
490 0 |a JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  |v 28 No. 10 
520 3 |a The recent discovery of mutations in the gene encoding diacylglycerol kinase epsilon (DGKE) identified a novel pathophysiologic mechanism leading to HUS and/or MPGN. We report ten new patients from eight unrelated kindreds with DGKE nephropathy. We combined these cases with all previously published cases to characterize the phenotypic spectrum and outcomes of this new disease entity. Most patients presented with HUS accompanied by proteinuria, whereas a subset of patients exhibited clinical and histologic patterns of MPGN without TMA. We also report the first two patients with clinical and histologic HUS/MPGN overlap. DGKE-HUS typically manifested in the first year of life but was not exclusively limited to infancy, and viral triggers frequently preceded HUS episodes. We observed signs of complement activation in some patients with DGKE-HUS, but the role of complement activation remains unclear. Most patients developed a slowly progressive proteinuric nephropathy: 80% of patients did not have ESRD within 10 years of diagnosis. Many patients experienced HUS remission without specific treatment, and a few patients experienced HUS recurrence despite complete suppression of the complement pathway. Five patients received renal allografts, with no post-transplant recurrence reported. In conclusion, we did not observe a clear genotype-phenotype correlation in patients with DGKE nephropathy, suggesting additional factors mediating phenotypic heterogeneity. Furthermore, the benefits of anti-complement therapy are questionable but renal transplant may be a feasible option in the treatment of patients with this condition. 
700 0 2 |a Simkova E Eva  |e aut 
700 0 2 |a Majid MA Mohammad Abdul  |e aut 
700 0 2 |a Galiano Matthias  |e aut 
700 0 2 |a Benz Kerstin  |e aut 
700 0 2 |a Amann Kerstin  |e aut 
700 0 2 |a Bockmeyer Clemens  |e aut 
700 0 2 |a Gajjar Radha  |e aut 
700 0 2 |a Meyers Kevin E.  |e aut 
700 0 2 |a Cheong Hae II  |e aut 
700 0 2 |a Lange-Sperandio Bärbel  |e aut 
700 0 2 |a Jungraithmayr Therese  |e aut 
700 0 2 |a Bereczki Csaba  |e aut 
700 0 2 |a Csuka Dorottya  |e aut 
700 0 2 |a Prohászka Zoltán  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/17677/1/3066.full.pdf  |z Dokumentum-elérés